Expert Interview
Evaluation of Roche’s Fenebrutinib: Advancing Relapsing MS Care Through Durable Suppression of Activity and Progression
Ticker(s): RHHBY, BIIBInstitution: Maryland Center of Neurology and Sleep
- Board Certified neurologist at Maryland Center of Neurology and Sleep
- Treats 50 patients with Alzheimer's Disease and 500 patients with Multiple Sclerosis
- Clinical interest in Alzheimer's Disease, multiple sclerosis and transverse myelitis management
How many patients do you manage that have Relapsing Multiple Sclerosis?
Added By: allan_adminOn a scale of (1-10) how excited are you for Roche’s fenebrutinib?
Added By: allan_adminWhat safety or tolerability considerations have emerged from the long-term data, and how might these findings influence future clinical development and positioning of fenebrutinib in the MS treatment landscape?
Added By: allan_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
